Cervical cancer technology company Truscreen Group Limited (ASX/NZX: TRU) (the Company) has released its preliminary unaudited financial results for the year ended 31 March 2024
TRU - CEO Resignation and Interim CEO Appointment sharechat.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sharechat.co.nz Daily Mail and Mail on Sunday newspapers.
ASX Health Stocks: Arovella to develop a world-first iNKT cell therapy targeting cancers theaustralian.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theaustralian.com.au Daily Mail and Mail on Sunday newspapers.